Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure

NCT02961829 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Infection
HIV

Interventions

DRUG: Maraviroc
DRUG: Dolutegravir
BIOLOGICAL: Dendritic Cell Vaccine
DRUG: Auranofin
DRUG: Sirtuin Histone deacetylase inhibitor

Sponsor

Federal University of São Paulo

Collaborators

[object Object]
[object Object]
[object Object]